Neuro-Oncology News

Raymond B. Wynn, MD, FACR, has been appointed vice chair of network operations in the department of radiation oncology at Loyola Medicine.

Researchers observed an inverse relationship between blood glucose levels and risk for glioma, according to an analysis of two study cohorts published in Scientific Reports.

The FDA today granted accelerated approval to pembrolizumab for adults and children with unresectable or metastatic, microsatellite instability–high or mismatch repair–deficient solid tumors.

The Conquer Cancer Foundation of ASCO announced the recipients of its Special Merit Awards.

The National Brain Tumor Society is calling for volunteers, patients, families, public policy advocates and physicians to act and join the society’s “brain tumor team” this month.

Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in CA: A Cancer Journal for Clinicians.

The addition of an investigational vaccine to chemotherapy led to unexpectedly longer survival for patients with glioblastoma, according to results of a small study published in Clinical Cancer Research.

The FDA granted breakthrough therapy designation to entrectinib for the treatment of NTRK fusion–positive locally advanced or metastatic solid tumors, according to the drug’s manufacturer.

The FDA granted orphan drug designation to larotrectinib for the treatment of solid tumors with neurotrophic tyrosine receptor kinase–fusion proteins, according to the drug’s manufacturer.

Edward Melian, MD, a radiation oncologist with Loyola Medicine, received the Chicago Radiological Society’s Distinguished Service Award.